CompletedNot Applicable

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

United States188 participantsStarted 2016-03-01

Plain-language summary

The goal of this clinical research study is to learn if light electrical stimulation to the wrist area during surgery is feasible in women having breast surgery.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults at least 18 years of age
✓. Female gender
✓. History of patient reported PONV, CINV or motion sickness
✓. Patients scheduled for Breast Surgery
✓. Sign an informed consent indicating they are aware of the investigational nature of this study.

Exclusion criteria

✕. Patients scheduled for paravertebral block
✕. Upper extremity deformity contralateral to the site of disease that could interfere with accurate point location or alter the energy pathway as defined by traditional acupuncture theory
✕. Local skin infections at or near the acustimulation site
✕. Pre-existing nausea and vomiting, defined as nausea or vomiting requiring pharmacological treatment greater than 3 times in the week preceding screening
✕. History of CVA or other central nervous system disorder resulting in residual weakness or paresis of extremity contralateral to the site of disease
✕. Grade III or IV upper extremity peripheral neuropathy
✕. Cardiac pacemakers. Patients involved in this protocol will receive electrical stimulation. For safety reasons, electrical stimulation should be avoided in patients with pacemakers
✕. Metal implants for the treatment extremity. For safety reasons, use of electrical stimulation should be avoided

What they're measuring

Efficacy of Intervention to Prevent Post-Operative Nausea and Vomiting (PONV)

Timeframe: During stay in post-operative anesthesia care unit, until discharge, an average of 1 day

Trial details

NCT IDNCT02473042

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-26

Results submitted2025-10-13

View on ClinicalTrials.gov More Post-Operative Nausea and Vomiting trials